US Biosimilars Market Will Benefit From Surge In Launches

Q&A With AmerisourceBergen's Senior Director Of Biosimilars, Sean McGowan

 
• By David Wallace
  
Lightning
The US Biosimilars market will be charged by a surge in recent launches • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products